Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL [Phase 2]

View source ↗

Summary

Phase 2, open-label, randomized multicenter trial evaluating matched sibling donor hematopoietic stem cell transplantation using total body irradiation or total…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• MSD-HSCT (Matched Sibling Donor Hematopoietic Stem Cell Transplantation)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Acute Lymphoblastic Leukemia, Adult | Phase 2 | Status: RECRUITING